Dr. Andrew Charles is director of Headache Research and Treatment, and professor of neurology at the David Geffen School of Medicine at UCLA. He leads the Goldberg Migraine Program, established in December 2015 with the largest single private grant ever for migraine research, in order to develop new treatments and research a potential cure. He has served on the board of directors for the American Headache Society since 2010, and the board of trustees for the International Headache Society since 2011. Dr. Charles educates neurologists, headache specialists and primary care physicians around the world on headache research and treatment. He’s also been published in numerous medical journals such as Neurology and Headache, and serves as an associate editor of Cephalalgia.
Interviews from Andrew Charles, MD
Shortening Attacks with Early Migraine Intervention
Neck Pain and Migraine: Trigger or Symptom
The New Era of Migraine: Hope and Help
6 Medications That Can Make Migraine Worse
Recognizing and Treating 4 Phases of Migraine
Dr. Shivang Joshi is a doctor, pharmacist, and migraine and pharmacology expert. He is board-certified in neurology and headache medicine. Dr. Joshi is also an associate professor of clinical pharmacy practice at the University at Buffalo School of Pharmacy. He is an award-winning researcher and teacher. He is a recipient of the American Headache Society’s 2012 “Frontiers in Headache Research” Scholarship Award for Cluster Headache Research, and the “Outstanding Teaching Award” from the Albert Einstein College of Medicine. He has recently joined DENT Neurologic Institute, where he treats existing and new patients.
Dr. Afridi qualified from Guy’s and St Thomas’ Medical School in London with an intercalated neuroscience degree. Following her basic medical training in London, she completed her PhD at the Institute of Neurology, Queen Square, looking at functional imaging in migraine. She then went on to complete her higher training in London and is a consultant neurologist at Guy’s and St Thomas’ NHS Foundation Trust, where she established the headache service in the neurology department. Her research interests include imaging in migraine and complex migraine aura. Dr. Afridi has been a council member of BASH (British Association for the Study of Headache) and is a trustee for The Migraine Trust. She was also on the scientific committee for The Migraine Trust International Symposium in 2018.
Dr. Michael Teixido is an otolaryngologist with a special interest in medical and surgical conditions that affect hearing and balance. He was born in Wilmington, Delaware, and developed an interest in ear surgery because of a hereditary hearing condition in his family. He actively pursues his goals to advance the study and understanding of problems involving hearing, balance, and general otolaryngology through his participation in many national professional organizations and through frequent lectures to his professional colleagues and the public. Dr. Teixido has taken a leadership role in otolaryngology in education on migraine and benign paroxysmal positional vertigo (BPPV), and he has established teaching tools and foundations to improve patient care.
Dr. Teixido has an active neurotologic practice. He is the director of the Delaware Otologic Medicine and Surgery Fellowship, director of the Balance and Mobility center of Christiana Care, and co-director of the Pediatric Cochlear Implant and Auditory Rehabilitation Program of the duPont Hospital for Children. He teaches residents in otolaryngology regularly at Thomas Jefferson, University of Pennsylvania, and Philadelphia College of Osteopathic Medicine.
Dr. Brian McGeeney, MD, MPH, is an assistant professor of neurology at the Boston University School of Medicine. He’s board certified in neurology, headache, and pain, and has a fellowship in pain management. In addition to his work at Boston University, he practices neurology at Boston Medical Center, and he’s a medical advisor at one of the largest and most active nonprofit organizations in the world for cluster patient advocacy: ClusterBusters.
Professor Zaza Katsarava is head of the department of neurology at the Evangelical Hospital in Unna, and a professor of neurology at the University of Essen in Germany. He is also the new president of the European Headache Federation and is active in numerous other organizations and boards for headache relief. His training in neurology began in Tbilisi, Georgia, and has since expanded to include the University of Essen in Germany, the Harvard School of Public Health, and the Johns Hopkins Bloomberg School of Public Health.
Professor Katsarava’s main interest focuses on headache and pain, especially the risk factors and mechanisms of chronic headache. He has used electrophysiological and imaging techniques to investigate the plasticity of the pain network in development of chronic headache. He is a principal investigator in several of the large scale population-based studies on predictors and risk factors of headache chronicity. He has published widely in peer-reviewed journals and elsewhere for over 20 years.
Dr. Lawrence Newman is a neurology professor at NYU Langone School of Medicine, Chair of the American Migraine Foundation and a migraine warrior himself. He truly understands the desperation we all feel when it seems like we’re out of treatment options. As director of the headache division at NYU Langone, Dr. Newman leads a team of board-certified neurologists and headache specialists to treat people who have migraine, cluster headache, trigeminal neuralgia, or other headache-related disorders using a variety of approaches — not just the standard therapies.
His research has been published in Neurology, Headache, Cephalalgia, and other medical journals. Dr. Newman is a member of the American Academy of Neurology, the National Headache Foundation, and the International Headache Society, and he is the former president of the American Headache Society. He’s an outside-the-box thinker who approaches every case with tenacity and humanity to find the best treatments for each person.
Professor Mitsikostas is a specialist in headache, a neurologist, council member of the European Headache Federation, and president of the Greek Headache Society. He received an MD from Aristotle’s University of Thessaloniki, and a PhD from the National and Kapodistrian University of Athens. He completed postdoctorate studies in molecular pharmacology of cephalic pain at Harvard Medical School and the University College of London. He is a member of the American Academy of Neurology, the Hellenic Neurology Society and the Hellenic Headache Society.
Anders Hougaard, MD, PhD, is a research fellow at the Danish Headache Center, Glostrup Hospital, Copenhagen, Denmark. He graduated from the University of Copenhagen in 2010, and is a member of the International Headache Society. Dr. Hougaard’s main research interests include pathophysiology of migraine with aura, human migraine models, neuroimaging and clinical trials of acute and preventive treatments of migraine. He has several publications on migraine in multiple peer-reviewed journals.
Dr. Antoinette Maassen van den Brink is an associate professor at the Erasmus University Medical Center Department of Pharmacology in The Netherlands. She has been studying migraine for more than 20 years, with recent emphasis on the role of female sex hormones in the disease’s neurovascular pharmacology. She serves as a board member for the Dutch Society for Gender & Health, the Dutch Pharmacological Society, the Federation of European Pharmacological Societies, the Dutch Headache Society and the European Headache Federation.
Dr. Christine Lay is a professor of neurology and the founding director of the headache program at the University of Toronto, where she holds the Deborah Ivy Christiani Brill chair for neurology research. She completed her residency at the Mayo Clinic and her headache fellowship at Albert Einstein College of Medicine in New York.
In addition to directing and growing the headache program at the University of Toronto and heading a very busy patient practice, she is actively involved in research and teaching. She directs the Canadian Headache Society fellowship program in Toronto; she is actively engaged in advocacy and education, serving as the chair of the American Migraine Foundation; and she is a board member of the American Headache Society and the Canadian Headache Society.
